Lung-uptake and -washout of MIBG in sarcoidosis

Respiratory Medicine

Volumn 102, Issue 1, 2008, Pages 64-70

  Jonker, Gerard J ^a   Smulders, Nanda M ^b   van Kroonenburgh, Marinus J ^b   Halders, Serve ^b   de Vries, Jolanda ^b,c   Faber, Carin G ^b   Drent, Marjolein ^b  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

Author keywords

Lung washout; MIBG; Sarcoidosis; Small fibre neuropathy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; NORADRENALIN;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CALCULATION; CATECHOLAMINE METABOLISM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; KINETICS; LUNG BLOOD VESSEL; LUNG FUNCTION; LUNG SARCOIDOSIS; MALE; MEASUREMENT; NEUROPATHY; PRIORITY JOURNAL; RADIODIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY;

3-IODOBENZYLGUANIDINE; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SARCOIDOSIS, PULMONARY; TEMPERATURE SENSE; TREATMENT OUTCOME;

EID: 36348960169     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.08.005     Document Type: Article

References (35)

1. Newman L.S., Rose C.S., and Maier L.A. Sarcoidosis. N Engl J Med 336 (1997) 1224-1234
2. Hoitsma E., Marziniak M., Faber C.G., et al. Small fibre neuropathy in sarcoidosis. Lancet 359 (2002) 2085-2086
3. Wieland D.M., Brown L.E., Rogers W.L., et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 22 (1981) 22-31
4. Tobes M.C., Jaques S.J., Wieland D.M., and Sisson J.C. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 26 (1985) 897-907
5. Murashima S., Takeda K., Matsumura K., et al. Increased lung uptake of iodine-123-MIBG in diabetics with sympathetic nervous dysfunction. J Nucl Med 39 (1998) 334-338
6. Nicholas T.E., Strum J.M., Angelo L.S., and Junod A.F. Site and mechanism of uptake of 3H-norepinephrine by isolated perfused rat lungs. Circ Res 35 (1974) 670-680
7. Slosman D.O., Davidson D., Brill A.B., and Alderson P.O. 131I-metaiodobenzylguanidine uptake in the isolated rat lung: a potential marker of endothelial cell function. Eur J Nucl Med 13 (1988) 543-547
8. Slosman D.O., Donath A., and Alderson P.O. 131I-metaiodobenzylguanidine and 125I-iodoamphetamine. Parameters of lung endothelial cell function and pulmonary vascular area. Eur J Nucl Med 15 (1989) 207-210
9. 123I-MIBG pulmonary removal: a biochemical marker of minimal lung endothelial cell lesions. Eur J Nucl Med 16 (1990) 633-637
10. Iwasawa Y., and Gillis C.N. Pharmacological analysis of norepinephrine and 5-hydroxytryptamine removal from the pulmonary circulation: differentiation of uptake sites for each amine. J Pharmacol Exp Ther 188 (1974) 386-393
11. Bryan-Lluka L.J., Westwood N.N., and O'Donnell S.R. Vascular uptake of catecholamines in perfused lungs of the rat occurs by the same process as uptake in noradrenergic neurones. Naunyn Schmiedebergs Arch Pharmacol 345 (1992) 319-326
12. Unlu M., and Inanir S. Prolonged lung retention of iodine-123-MIBG in diabetic patients. J Nucl Med 39 (1998) 116-118
13. Hoitsma E., Faber C.G., van Kroonenburgh M.J., et al. Association of small fiber neuropathy with cardiac sympathetic dysfunction in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 (2005) 43-50
14. Hunninghake G.W., Costabel U., Ando M., et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 (1999) 149-173
15. Eisenhofer G. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91 (2001) 35-62
16. Antonelli Incalzi R., Fuso L., Giordano A., et al. Neuroadrenergic denervation of the lung in type I diabetes mellitus complicated by autonomic neuropathy. Chest 121 (2002) 443-451
17. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 5-40
18. DeRemee R.A. The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest 83 (1983) 128-133
19. Yarnitsky D. Quantitative sensory testing. Muscle Nerve 20 (1997) 198-204
20. Hoitsma E., Drent M., Verstraete E., et al. Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin Neurophysiol 114 (2003) 2326-2333
21. Yarnitsky D., and Sprecher E. Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 125 (1994) 39-45
22. Sole M.J., Drobac M., Schwartz L., Hussain M.N., and Vaughan-Neil E.F. The extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension. Circulation 60 (1979) 160-163
23. Tseng Y.T., and Padbury J.F. Expression of a pulmonary endothelial norepinephrine transporter. J Neural Transm 105 (1998) 1187-1191
24. Suga K., Kume N., Shimizu K., et al. Potential of iodine-123 metaiodobenzylguanidine single-photon emission tomography to detect abnormal functional status of the pulmonary neuroadrenergic system in irradiated lung. Eur J Nucl Med 26 (1999) 647-654
25. Koizumi T., Kubo K., Hanaoka M., et al. Serial scintigraphic assessment of iodine-123 metaiodobenzylguanidine lung uptake in a patient with high-altitude pulmonary edema. Chest 116 (1999) 1129-1131
26. Yoshiike F., Koizumi T., Urushihata K., Hanaoka M., and Kubo K. Reduced lung uptake of iodine-123 metaiodobenzylguanidine in patients with myeloperoxidase antineutrophil cytoplasmic antibodies-positive vasculitis. Respiration 73 (2006) 191-196
27. Mu X., Hasegawa S., Yoshioka J., et al. Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure. Ann Nucl Med 15 (2001) 411-416
28. Unlu M., Akincioglu C., Yamac K., and Onder M. Pulmonary involvement in Behcet's disease: evaluation of 123 I-MIBG retention. Nucl Med Commun 22 (2001) 1083-1088
29. 123I-MIBG lung scintigraphy. Eur J Nucl Med Mol Imaging 32 (2005) 221-228
30. Arao T., Takabatake N., Sata M., et al. In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. J Nucl Med 44 (2003) 1747-1754
31. Hoitsma E., Reulen J.P., de Baets M., Drent M., Spaans F., and Faber C.G. Small fiber neuropathy: a common and important clinical disorder. J Neurol Sci 227 (2004) 119-130
32. Shulkin B.L., Shapiro B., Tobes M.C., et al. Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine. J Nucl Med 27 (1986) 1138-1142
33. Mangner T.J., Tobes M.C., Wieland D.W., Sisson J.C., and Shapiro B. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma. J Nucl Med 27 (1986) 37-44
34. Nakajo M., Shimabukuro K., Yoshimura H., et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 27 (1986) 84-89
35. Kanzaki N., Soda R., Takahashi K., et al. Influence of age and gender on iodine-123 MIBG kinetics in normal lung. Ann Nucl Med 12 (1998) 225-229